Imunon
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Imunon and other ETFs, options, and stocks.About IMNN
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies.
CEOStacy R. Lindborg
CEOStacy R. Lindborg
Employees25
Employees25
HeadquartersLawrenceville, New Jersey
HeadquartersLawrenceville, New Jersey
Founded1982
Founded1982
Employees25
Employees25
IMNN Key Statistics
Market cap12.03M
Market cap12.03M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume80.58K
Average volume80.58K
High today$5.14
High today$5.14
Low today$4.60
Low today$4.60
Open price$5.11
Open price$5.11
Volume204.10K
Volume204.10K
52 Week high$47.40
52 Week high$47.40
52 Week low$4.60
52 Week low$4.60
IMNN News
TipRanks 1d
Imunon to present Phase 3 OVATION trial of IMNN-001IMUNON (IMNN) announced that a trials-in-progress abstract on the ongoing Phase 3 OVATION 3 clinical trial of IMNN-001, its investigational therapy for the trea...
People also own
Based on the portfolios of people who own IMNN. This list is generated using Robinhood data, and it’s not a recommendation.